Huntington Potter, PhD

Neurology and Linda Crnic Institute for Down Syndrome  University of Colorado, Boulder, Boulder, CO, United States 
Alzheimer's Disease, Down Syndrome
"Huntington Potter"
Mean distance: 9030.93
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Potter H, Woodcock JH, Boyd TD, et al. (2021) Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 7: e12158
Bubak AN, Beseler C, Como CN, et al. (2020) Amylin, Aβ42, and Amyloid in VZV Vasculopathy Cerebrospinal Fluid and Infected Vascular Cells. The Journal of Infectious Diseases
Potter H, Boyd TD, Clarke P, et al. (2020) Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19. F1000research. 9: 345
Coughlan C, Bruce KD, Burgy O, et al. (2020) Exosome Isolation by Ultracentrifugation and Precipitation and Techniques for Downstream Analyses. Current Protocols in Cell Biology. 88: e110
Bubak AN, Como CN, Coughlan CM, et al. (2019) Varicella Zoster Virus Infection of Primary Human Spinal Astrocytes Produces Intracellular Amylin, Amyloid-beta, and an Amyloidogenic Extracellular Environment. The Journal of Infectious Diseases
Pelak VS, Tang-Wai DF, Bouwman FH, et al. (2019) P1-311: Development Of An International Posterior Cortical Atrophy Bioregistry Alzheimers & Dementia. 15
Jim HS, Boyd TD, Booth-Jones M, et al. (2012) Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients. Brain Disorders & Therapy. 1
See more...